A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
C1INHF | C1-INH funkt. | % | 70.0 | - | 130.0 | MATERIAL: Citrat+Serum |
C1INHQ | C1-INH quant. | g/l | 0.210 | - | 0.380 | MATERIAL: Citrat+Serum |
C24_C22_R | C24/C22 Ratio | < | 1.000 | MATERIAL: Serum; METHODE: Calc. | ||
C26_C22_R | C26/C22 Ratio | < | 0.020 | MATERIAL: Serum; METHODE: Calc. | ||
CA125 | CA 125 | U/ml | 0.0 | - | 35.0 | MATERIAL: Serum, METHODE: MEIA |
CA15-3 | CA 15-3 | U/ml | 0.0 | - | 35.0 | MATERIAL: Serum, METHODE: MEIA |
CA19-9 | CA 19-9 | U/ml | 0.0 | - | 37.0 | MATERIAL: Serum, METHODE: CMIA |
CA72-4 | CA 72-4 | U/ml | 0.00 | - | 6.90 | MATERIAL: Serum, METHODE: EIA |
CDU | Cadmium i.Harn | ug/l | 0.000 | - | 0.800 | MATERIAL: Spontanharn, METHODE: AAS |
CDUKR | Cadmium i.Harn / g Krea | ug/g Krea | 0.000 | - | 2.500 | MATERIAL: Spontanharn, METHODE: |
CDH | Cadmium im 24h-Harn | ug/24h | 0.000 | - | 2.250 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
CDV | Cadmium im Vollblut (EDTA) | ug/dl | 0.000 | - | 0.100 | MATERIAL: EDTA, METHODE: AAS |
VGCCAKN | Ca-Kanal(VGCC)-AK (N-Typ) | Ak-RATIO | 0.000 | - | 15.000 | MATERIAL: Serum, Methode: RIA |
VGCCAKPQ | Ca-Kanal(VGCC)-AK (P/Q-Typ) | pmol/l | 0.0 | - | 30.0 | MATERIAL: Serum, Methode: RIA |
CALC | Calcitonin | pg/ml | 0.000 | - | 9.520 | MATERIAL: Serum, METHODE: EIA |
CA | Calcium | mmol/l | 2.100 | - | 2.600 | MATERIAL: Serum, METHODE: photometrisch |
CAV | Calcium i.Vollblut | mg/dl | 4.600 | - | 6.600 | MATERIAL: EDTA, METHODE: AAS |
CAH | Calcium im 24h-Harn | mmol/24h | 2.500 | - | 7.500 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
CAION | Calcium ionisiert (berechnet) | mmol/l | 2.100 | - | 2.600 | MATERIAL: Serum/Vollblut, METHODE:photometrisch |
CAKREAQ | Calcium Kreatinin Ratio | mmol/mmol | 0.000 | - | 0.570 | |
CALPROTS | Calprotectin | ug/l | 0.00 | - | 3000.00 | MATERIAL: Serum, |
CALPROTST | Calprotectin (St) | mg/kg | 0.00 | - | 50.00 | MATERIAL: Stuhl, METHODE: ELISA |
CALRETEX9 | Calreticulin Ex9 Mutation | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
CAMP | Campylobacter | - | MATERIAL: Serum/Vollblut, METHODE: KBR | |||
CAMPAG | Campylobakter Erregernachweis | - | MATERIAL: Stuhl, | |||
CAMPA | Campylobakter IgA | U/ml | 0.00 | - | 24.00 | MATERIAL: Serum, METHODE: ELISA |
CAMPG | Campylobakter IgG | U/ml | 0.00 | - | 24.00 | MATERIAL: Serum, METHODE: ELISA |
CANCA | C-ANCA (anti-PR-3) | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum, METHODE: CLIA |
CANDAG | Candida Antigen im Serum | - | MATERIAL: Serum, METHODE: Agglutination | |||
CANDA | Candida IgA | IU/ml | 0.000 | - | 80.000 | MATERIAL: Serum, METHODE: ELISA |
CANDG | Candida IgG | IU/ml | 0.000 | - | 100.000 | MATERIAL: Serum, METHODE: ELISA |
CANDM | Candida IgM | IU/ml | 0.000 | - | 80.000 | MATERIAL: Serum, METHODE: ELISA |
ABCAND | Candida im Abstrich | - | MATERIAL: Abstrich, METHODE: Kultur | |||
CANS | Cannabinoide (S) | ug/l | 0.00 | - | 10.00 | MATERIAL: Serum, METHODE: FPIA |
CANH | Cannabinoide (U) | ng/ml | 0.0 | - | 50.0 | MATERIAL: Spontanharn, METHODE: EMIT |
CARBA | Carbamazepin | ug/ml | 4.00 | - | 12.00 | MATERIAL: Serum, METHODE: FPIA |
CAH_I_Ak | Carboanhydrase I Ak | - | MATERIAL: Serum, METHODE: EIA | |||
CAH_II_Ak | Carboanhydrase II Ak | - | MATERIAL: Serum, METHODE: EIA | |||
ACLAA | Cardiolipin-AK IgA | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: ELISA |
ACLAG | Cardiolipin-AK IgG | U/ml | 0.00 | - | 12.00 | MATERIAL: Serum, METHODE: ELISA |
ACLAM | Cardiolipin-AK IgM | U/ml | 0.00 | - | 12.00 | MATERIAL: Serum, METHODE: ELISA |
CARIPRAZIN | Cariprazin | ug/l | 10.00 | - | 20.00 | MATERIAL: Serum, METHODE: LC-MS |
CARN | Carnitin (freies) | mg/l | 4.00 | - | 9.80 | MATERIAL: Serum, METHODE: MS |
COMP | Cartilage Olig.Matrix Protein | U/l | 0.0 | - | 15.0 | MATERIAL: Serum, METHODE: EIA |
CASPR2AK | CASPR2-AK (IgG) | Titer | 0.00 | - | 10.00 | MATERIAL: Serum, Methode: IFT |
ASPAGBEURT | Cave Asp.-AG (Galaktomannan): | - | MATERIAL: Serum, METHODE: ELISA | |||
CDT | CDT-IFCC | % | 0.00 | - | 2.00 | MATERIAL: Serum, METHODE: HPLC |
CEA | CEA | ng/ml | 0.00 | - | 3.00 | MATERIAL: Serum, METHODE: CMIA |
CENOBAMAT | Cenobamat | mg/l | 5.00 | - | 35.00 | MATERIAL: 2xSerum; METHODE: LC-MS |
ACA | Centromer AK | - | MATERIAL: Serum; METHODE: IFT/Blot | |||
CENPB | Centromer AK (quantitativ) | EliAU/ml | 0.00 | - | 6.90 | MATERIAL: Serum, METHODE: |
CEROTINSRE | Cerotinsäure C26:0 | umol/l | 0.20 | - | 1.60 | MATERIAL: Serum Methode: GC-MS |
CH100 | CH100 | U/ml | 392.0 | - | 1019.0 | MATERIAL: Serum, |
CH50 | CH-50 | U/ml | 32.0 | - | 58.0 | MATERIAL: Serum, METHODE: turbidimetrisch |
CHL_L1-L3 | Chl.trach. DNA L1-L3 | - | MATERIAL: Abstrich, METHODE: PCR | |||
CHL_L1-L3H | Chl.trach. DNA L1-L3 i.Harn | - | MATERIAL: Spontanharn, METHODE: PCR | |||
CHL_ompA | Chl.trach. DNA ompA Gen | - | MATERIAL: Abstrich, METHODE: PCR | |||
CHL_ompAH | Chl.trach. DNA ompA Gen i.Harn | - | MATERIAL: Spontanharn, METHODE: PCR | |||
CHLPCRU | Chl.trach.PCR i.H./Abstrich | - | MATERIAL: Spontanharn, METHODE: PCR | |||
CHLPCR | Chl.trachomatis DNA (PCR) | - | MATERIAL: Serum/Sputum/Punktat, METHODE: PCR | |||
CHLPNEUA | Chlamydia pneumoniae IgA | U/ml | 0.00 | - | 25.00 | MATERIAL: Serum, METHODE: Immunfluoreszenz |
CHLPNEUG | Chlamydia pneumoniae IgG | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
CHLPNEUM | Chlamydia pneumoniae IgM | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
CHLPSIT | Chlamydia psittaci (KBR) | 0.0 | - | 19.9 | MATERIAL: Serum, METHODE: KBR | |
CHLPSITA | Chlamydia psittaci IgA | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT | |
CHLPSITG | Chlamydia psittaci IgG | 0.0 | - | 100.0 | MATERIAL: Serum, METHODE: IFT | |
CHLPSITM | Chlamydia psittaci IgM | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT | |
CHLPCRAB | Chlamydia trach.(PCR) i.Abstr. | - | MATERIAL: Abstrich, METHODE: PCR | |||
CHLTRACHA | Chlamydia trachomatis IgA | - | MATERIAL: Serum, METHODE: ELISA | |||
CHLTRACHG | Chlamydia trachomatis IgG | - | MATERIAL: Serum, METHODE: ELISA | |||
CL | Chlorid | mmol/l | 95.0 | - | 110.0 | MATERIAL: Serum, METHODE: ISE |
CLH | Chlorid im 24h-Harn | mmol/24h | 2.0 | - | 250.0 | MATERIAL: 24h-Sammelharn, METHODE: ISE |
CHLORPROT | Chlorprothixen | ng/ml | 20.00 | - | 300.00 | MATERIAL: Serum, METHODE: LC-MS |
CHOL | Cholesterin | mg/dl | < | 200.0 | MATERIAL: Serum, METHODE: photometrisch | |
CHOLRAT | Cholesterin-Ratio | - | ||||
CHE | Cholinesterase | kU/l | 2.90 | - | 12.90 | MATERIAL: Serum, METHODE: photometrisch |
CRU | Chrom i.Harn | ug/l | 0.000 | - | 0.600 | MATERIAL: Spontanharn, METHODE: AAS |
CRH | Chrom im 24h-Harn | ug/24h | 0.00 | - | 0.90 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
CR | Chrom im Serum | ug/l | 0.000 | - | 0.500 | MATERIAL: Serum, METHODE: AAS |
CRV | Chrom im Vollblut (EDTA) | ug/l | 0.500 | - | 4.000 | MATERIAL: EDTA, METHODE: AAS |
CGA | Chromogranin A | ug/l | 0.00 | - | 100.00 | MATERIAL: Serum, Methode: LIA (TRIF) |
CIC1Q | CIC-C1q-IgG | ug/ml | 0.0 | - | 45.0 | MATERIAL: Serum/Vollblut, METHODE: ID |
CIC3D | CIC-C3d-IgG | ug/ml | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
CITALO | Citalopram | ng/ml | 50.00 | - | 110.00 | MATERIAL: Serum, METHODE: HPLC |
CITRATH | Citrat im 24h-Harn | mg/24h | 300.00 | - | 860.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: GC-MS |
CITRULLINU | Citrullin i.Harn | mmol/mol Kr | 0.00 | - | 4.00 | MATERIAL: 2.Morgenharn, Methode: LC-MS |
CK | CK | U/l | 29.00 | - | 200.00 | MATERIAL: Serum, METHODE: photometrisch |
CKBB-E | CK-BB | % | - | MATERIAL: Serum, METHODE: ELPHOR | ||
CKELPHOR | CK-Isoenzym-Elektrophorese | - | MATERIAL: Serum/Vollblut | |||
CKMB-E | CK-MB | % | 0.00 | - | 3.00 | MATERIAL: Serum, METHODE: ELPHOR |
CKMB | CK-MB | U/l | 0.0 | - | 24.0 | MATERIAL: Serum, METHODE: photometrisch |
CKMB% | CK-MB relativ | % | - | MATERIAL: Serum/Vollblut, METHODE: GC/MS | ||
CKMM-E | CK-MM | % | 97.00 | - | 100.00 | MATERIAL: Serum, METHODE: ELPHOR |
CLINDA | Clindamycin | mg/l | - | MATERIAL: Serum, METHODE: | ||
CLOBA | Clobazam | ug/l | 30.00 | - | 300.00 | MATERIAL: Serum, METHODE: LC-MS/MS |
CLOMIPRAM | Clomipramin | ng/ml | - | MATERIAL: Serum, METHODE: LC-MS | ||
CLOMI_GES | Clomipramin + Norclomipramin | ng/ml | 230.00 | - | 450.00 | |
CLONA | Clonazepam | ug/l | 10.00 | - | 80.00 | MATERIAL: Serum, METHODE: LC-MS |
CLOS | Clos.diff.Toxinnachweis | - | MATERIAL: Stuhl, | |||
CLOZ | Clozapin | ng/ml | 350.00 | - | 600.00 | MATERIAL: Serum, METHODE: LC-MS |
CLOZDESME | Clozapin (Desmethyl-) | ng/ml | - | MATERIAL: Serum, METHODE: LC-MS | ||
CLNORQ_STA | Clozapin-Norclozapin-Quotient | 1.000 | - | 2.500 | ||
CLOZNOXID | Clozapin-N-Oxid | ng/ml | 15.00 | - | 140.00 | MATERIAL: Serum, METHODE: LC-MS |
CMV | CMV IgG | - | MATERIAL: Serum, METHODE: ELFA | |||
CMVM | CMV IgM | - | MATERIAL: Serum, METHODE: ELFA | |||
CMVPCR | CMV-Virus DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
COU | Cobalt i.Harn | ug/l | 0.00 | - | 1.00 | MATERIAL: Spontanharn, METHODE: AAS |
COUKR | Cobalt i.Harn / g Krea | ug/g Krea | - | MATERIAL: Spontanharn, METHODE: AAS/Clia | ||
COH | Cobalt im 24h-Harn | ug/24h | 0.00 | - | 1.50 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
CO | Cobalt im Serum | ug/l | 0.00 | - | 0.60 | MATERIAL: Serum/Vollblut, METHODE: ICP-MS |
COCS | Cocainmetabolite (S) | ug/l | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: FPIA |
COCH | Cocainmetabolite (U) | ng/ml | 0.0 | - | 300.0 | MATERIAL: Spontanharn, METHODE: EMIT |
COERU | Coeruloplasmin | mg/dl | 15.00 | - | 45.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
COFF | Coffein (S) | ug/ml | 5.000 | - | 20.000 | MATERIAL: Serum, METHODE: HPLC |
C2_comp | Complement C2 | mg/dl | 14.00 | - | 25.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
C3_comp | Complement C3 | mg/dl | 90.00 | - | 180.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
C4_comp | Complement C4 | mg/dl | 10.00 | - | 40.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
DCT | Coombstest direkt | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
CORT | Cortisol | ug/dl | 4.80 | - | 19.50 | MATERIAL: Serum, METHODE: LIA |
CORTH | Cortisol im 24h-Harn | ug/24h | 11.50 | - | 102.00 | MATERIAL: 24h-Sammelharn, METHODE: LIA |
CORT_SP | Cortisol im Speichel | ug/dl | 0.0000 | - | 0.8740 | MATERIAL: Speichel, METHODE: ECLIA |
COTS | Cotinin | µg/l | 0.0 | - | 10.0 | MATERIAL: Serum, |
COTU | Cotinin i.Harn | ng/ml | 0.0 | - | 20.0 | MATERIAL: Spontanharn, |
COVMAB | COVID19 IgM-Ak (Diasorin) | - | MATERIAL: Serum, METHODE: CMIA | |||
COVNUKAB | COVID19 N-Kapsid AK (Roche) | - | MATERIAL: Serum, METHODE: immunologisch | |||
CPEP | C-Peptid | ng/ml | 1.10 | - | 4.40 | MATERIAL: Serum, METHODE: LIA |
CRP | CRP | mg/dl | 0.000 | - | 0.500 | MATERIAL: Serum, METHODE: turbidimetrisch |
CRPP | CRP im Punktat | mg/dl | - | MATERIAL: Punktat, METHODE: turbidimetrisch | ||
CRYPTOST | Cryptosporidien im Stuhl | - | MATERIAL: Stuhl, | |||
COPA | CT-proAVP (Copeptin) | pmol/l | - | MATERIAL: Serum/Vollblut | ||
CTX_V | CTX (ß-Crosslaps) | ng/ml | 0.000 | - | 1.000 | MATERIAL: Serum, Methode: ECLID |
CTX | CTX (ß-Crosslaps) | ng/l | 118.0 | - | 1060.0 | MATERIAL: Serum, Methode: ECLID |
CCPAK | Cycl. Citrullin Peptid-AK | U/ml | 0.000 | - | 5.000 | MATERIAL: Serum, Methode: EIA |
CYCLO | Cyclosporin A monokl. | ug/l | - | MATERIAL: EDTA, METHODE: FPIA | ||
CYFRA | CYFRA 21-1 | ng/ml | 0.000 | - | 2.370 | MATERIAL: Serum, METHODE: TRACE |
CYPP450 | CYP P450 | - | MATERIAL: EDTA (5ml), Methode: Gentest | |||
CYSTATU | Cystathionin i.Harn | ug/l | 80.00 | - | 11000.00 | MATERIAL: 2.Morgenharn, Methode: LC-MS |
CYSC | Cystatin C | mg/l | 0.590 | - | 1.380 | MATERIAL: Serum, Methode: Immunturbidimetrie |
CMVAVID | Cytomegalie IgG Avidität | - | MATERIAL: Serum, | |||
CMVKBR | Cytomegalie KBR | Titer | 0.0 | - | 40.0 | MATERIAL: Serum, METHODE: KBR |
CYTABS | Cytotoxische Zellen absolut | /mm3 | 0.0 | - | 70.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
CYTREL | Cytotoxische Zellen relativ | % | 0.0 | - | 3.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |